72,862 CVS Health Corporation $CVS Shares Sold by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. reduced its stake in CVS Health Corporation (NYSE:CVS – Free Report) by 88.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,452 shares of the pharmacy operator’s stock after selling 72,862 shares during the period. Landscape Capital Management L.L.C.’s holdings in CVS Health were worth $810,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of CVS. Elevation Wealth Partners LLC grew its position in CVS Health by 41.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 105 shares during the last quarter. HBW Advisory Services LLC raised its holdings in CVS Health by 3.5% in the third quarter. HBW Advisory Services LLC now owns 3,408 shares of the pharmacy operator’s stock worth $292,000 after buying an additional 115 shares during the last quarter. Apella Capital LLC lifted its stake in shares of CVS Health by 1.7% in the second quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock worth $724,000 after buying an additional 117 shares in the last quarter. Wellington Altus USA Inc. lifted its stake in shares of CVS Health by 13.3% in the second quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock worth $106,000 after buying an additional 120 shares in the last quarter. Finally, Childress Capital Advisors LLC grew its holdings in shares of CVS Health by 3.9% during the third quarter. Childress Capital Advisors LLC now owns 3,497 shares of the pharmacy operator’s stock valued at $300,000 after buying an additional 131 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

More CVS Health News

These are some of the CVS news items that stood out recently:

  • Positive Sentiment: CVS ranked ninth on a recent “affordable blue chip stocks” list, which may reinforce its value-stock appeal, but the ranking itself is not a fundamental change to the business. Article: Why CVS Health cracked the Best Affordable Blue Chip Stocks list
  • Neutral Sentiment: Aetna launched a five-year maternal and infant-care initiative, targeting access to essential care for 90% of members by 2032. It may support member engagement over time, but the announcement offers no clear near-term earnings impact. Article: Aetna For You & Baby initiative
  • Negative Sentiment: Renewed momentum for “Medicare for All” was cited as a factor weighing on health-insurer stocks. The prospect of major changes to private insurance could create sector-wide uncertainty for CVS and its Aetna business. Article: Medicare For All momentum sinks health insurer stocks

CVS Health Stock Up 1.0%

CVS opened at $80.83 on Friday. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a 50 day moving average price of $88.42 and a 200-day moving average price of $89.29. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The stock has a market capitalization of $103.42 billion, a price-to-earnings ratio of 9.41, a PEG ratio of 0.77 and a beta of 0.58.

CVS Health (NYSE:CVS – Get Free Report) last announced its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.65 by $0.44. The business had revenue of $108.40 billion during the quarter, compared to analyst estimates of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The company’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.60 EPS. Equities research analysts forecast that CVS Health Corporation will post 8.26 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a $0.6650 dividend. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s dividend payout ratio is currently 30.97%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on CVS shares. Jefferies Financial Group reissued a “buy” rating and set a $103.00 price target on shares of CVS Health in a research report on Wednesday, November 4th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of CVS Health in a research report on Friday, October 9th. Wells Fargo & Company cut their target price on CVS Health from $123.00 to $112.00 and set an “overweight” rating on the stock in a research note on Thursday, November 12th. Argus lifted their target price on CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, August 19th. Finally, Robert W. Baird set a $107.00 price target on CVS Health in a research note on Thursday, August 6th. Twenty-three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $107.33.

Get Our Latest Stock Analysis on CVS

Insiders Place Their Bets

In other news, EVP Prem Shah bought 23,855 shares of the company’s stock in a transaction on Friday, November 6th. The shares were acquired at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the completion of the transaction, the executive vice president owned 88,516 shares of the company’s stock, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.85% of the company’s stock.

About CVS Health

(Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Featured Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.